Klaus-Peter Hirth
33Patents
19h-index
56Co-inventors
84Inventor score
Filing activity: Mar 10, 1993 → Dec 11, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7863288B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 147 | Active |
| US8143271B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 114 | Active |
| US5789427A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 95 | Expired |
| US8470818B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 87 | Active |
| US5773476A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 85 | Expired |
| US5763198A | Screening assays for compounds | Physics | 84 | Expired |
| US8415469B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 81 | Active |
| US6331555A | Treatment of platelet derived growth factor related disorders such as cancers | Human Necessities | 81 | Expired |
| US5700823A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 76 | Expired |
| US5942385A | Method for molecular diagnosis of tumor angiogenesis and metastasis | Chemistry; Metallurgy | 74 | Expired |
| US5990141A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 47 | Expired |
| US7872018B2 | Compounds and methods for kinase modulation, and indications therefor | Human Necessities | 47 | Active |
| US6610688B2 | 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors | Chemistry; Metallurgy | 46 | Expired |
| US6696448B2 | 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors | Physics | 45 | Expired |
| US9358235B2 | Kinase modulation, and indications therefor | Human Necessities | 39 | Active |
| US5700822A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6004967A | Psoriasis treatment with quinazoline compounds | Human Necessities | 25 | Expired |
| US9730918B2 | Kinase modulation, and indications therefor | Human Necessities | 22 | Active |
| US9873700B2 | Compounds for kinase modulation, and indications therefor | Chemistry; Metallurgy | 19 | Active |
| US6147106A | Indolinone combinatorial libraries and related products and methods for the treatment of disease | Chemistry; Metallurgy | 16 | Expired |
| US6596878B2 | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 15 | Expired |
| US6846839B1 | Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis | Physics | 14 | Expired |
| US5932602A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 10 | Expired |
| US10123998B2 | Kinase modulation, and indications therefor | Human Necessities | 8 | Active |
| US6906093B2 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | Physics | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.